Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects. (Q50494282)
Jump to navigation
Jump to search
scientific article published in October 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects. |
scientific article published in October 2000 |
Statements
1 reference
Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects. (English)
1 reference
Arnaout MK
1 reference
Radomski KM
1 reference
Srivastava DK
1 reference
Tong X
1 reference
Belt JR
1 reference
Raimondi SC
1 reference
Behm FG
1 reference
Santana VM
1 reference
Crom WR
1 reference
Mirro J Jr
1 reference
Ribeiro RC
1 reference
1 October 2000
1 reference
1 reference
14
1 reference
10
1 reference
1736-1742
1 reference
Identifiers
1 reference